Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Opus Genetics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 50 | 1 | 50 | +1 |
| Shares | 3.77M | 15.0K | 3.71M | −40.6K (−1.1%) |
| Value | $12.6M | $50.3K | $11.2M | −$1.40M (−11.1%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Opus Genetics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 85,866 | $258.5K | 0.00% |
| Anson Funds Management LP | 49,339 | $148.5K | 0.03% |
| Victory Capital Management Inc | 46,916 | $141.2K | 0.00% |
| Jane Street Group, LLC | 34,691 | $104.4K | 0.00% |
| Renaissance Technologies LLC | 24,225 | $73.0K | 0.00% |
| Citadel Advisors LLC | 15,275 | $46.0K | 0.00% |
| Prudential Financial Inc | 13,400 | $40.3K | 0.00% |
| UBS Group AG | 5,398 | $16.2K | 0.00% |
| ICA Group Wealth Management, LLC | 30 | $90 | 0.00% |
| Bank of America Corp | 27 | $81 | 0.00% |
| GWM Advisors LLC | 19 | $57 | 0.00% |
| FSA Wealth Management LLC | 5 | $0 | 0.00% |
Sold out (11)
Institutions that held Opus Genetics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Acadian Asset Management LLC | 49,563 | $165.0K |
| Stratos Wealth Partners, LTD. | 23,925 | $80.1K |
| O'Shaughnessy Asset Management, LLC | 18,137 | $60.8K |
| Thompson Davis & Co., Inc. | 17,000 | $57.0K |
| Gsa Capital Partners LLP | 13,588 | $46.0K |
| Pinebridge Investments, L.P. | 10,746 | $36.0K |
| Private Advisor Group, LLC | 10,200 | $34.2K |
| Legato Capital Management LLC | 10,098 | $33.8K |
| JPMorgan Chase & Co | 8,474 | $28.4K |
| TD Waterhouse Canada Inc. | 40 | $145 |
| New England Capital Financial Advisors LLC | 20 | $67 |
Not filed for Q4 2023 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Bedel Financial Consulting Inc | 15,000 | $50.3K |